What we are studying
The purpose of this study is to see if an investigational medicine called BIO101 could be used to treat sarcopenia, including sarcopenic obesity, in the elderly. Sarcopenia is characterized by a progressive loss of muscle mass and decreased muscle capacity, which appears around age fifty and involves an increased risk of falls and fractures.
Yes. The study team will provide more information.